TY - JOUR T1 - Inhibitory Effect of Orally-administered Sulfated Polysaccharide Ascophyllan Isolated from <em>Ascophyllum nodosum</em> on the Growth of Sarcoma-180 Solid Tumor in Mice JF - Anticancer Research JO - Anticancer Res SP - 1663 LP - 1671 VL - 34 IS - 4 AU - ZEDONG JIANG AU - RYOGO ABU AU - SHOGO ISAKA AU - SATORU NAKAZONO AU - MIKINORI UENO AU - TAKASI OKIMURA AU - KENICHI YAMAGUCHI AU - TATSUYA ODA Y1 - 2014/04/01 UR - http://ar.iiarjournals.org/content/34/4/1663.abstract N2 - We evaluated the antitumor activity of crude extract and ascophyllan prepared from Ascophyllum nodosum in sarcoma-180 solid tumor-bearing mice with continuous intraperitoneal (i.p.) administration at a dose of 50 mg/kg body weight/day or oral administration at a dose of 500 mg/kg body weight/day. Ascophyllan and crude extract administered via the oral route showed greater antitumor effects than via i.p. route, and the tumor sizes in mice treated with ascopyllan and crude extract were reduced by a mean of 68.7±6.8% and 42.4±24.8% by the oral route, and 41.4±16.1% and 13.6±20.6% by i.p. route compared to control mice. Splenic natural killer cell activity in the mice treated with ascophyllan and crude extract by i.p. route was significantly enhanced, while only a slight increase of this activity was observed in orally-treated mice. Furthermore, increase in spleen weight of tumor-bearing mice was slightly suppressed by oral administration of ascophyllan, whereas i.p. administration resulted in further enlargement. Analysis of serum cytokines revealed that oral treatment with ascophyllan resulted in significant increase of tumor necrosis factor-α and interleukin-12 levels. Since ascophyllan showed no direct cytotoxic effect on sarcoma-180 cells, orally-administered ascophyllan is suggested to exhibit its antitumor activity through the activation of the host immune system. ER -